Thus, AC262 Sarm has been identified as a relatively partial agonist concerning the natural androgen testosterone, which means that it stimulates a particular receptor (in this case, the androgen receptor) but not entirely to the capability of testosterone. Pre-clinical studies in animals have demonstrated that it can improve anabolic parameters significantly, mainly by stimulating muscle growth and lowering a condition known as elevated LH levels.
Unlike testosterone, AC262 Sarm does not have 'considerable' androgenic effects, measured as higher prostate and seminal vesicle weights. This would suggest that it confers the muscle-building effects of androgens without the chance of some of these hormones' side effects, such as enlargement of the prostate gland [1].
However, SARMs such as AC262 Sarm are not clinically approved; instead, they are being investigated as potential therapies in:
Osteoporosis
Alzheimer's disease
Breast cancer
Muscle wasting conditions .
https://www.hormonerawsource.com/sarm-powders/sarms-powders/superior-quality-ac-262536-powder-for.html
